PS

Packiri Samy Porselvi

Active Director Director DIN 10459791
DIN 10459791 First appointment Jan 2024
Unlock full profile Investments · shareholding · contact details
Current companies 1 active board seats
Total affiliations 1 Since Jan 2024
Shareholding value •••• Premium profile

About Packiri Samy Porselvi

Data last updated:

Packiri Samy Porselvi is a Director at Grasp Pharamaceuticals Private Limited (since 2024). Grasp Pharamaceuticals Private Limited reported revenue of ₹4.5 Lakh (FY 2025).

DIN 10459791
Primary Designation Director
First Appointment 10 Jan 2024
Oldest Company Age 2 yrs
Largest company Grasp Pharamaceuticals Private Limited · ₹4.5 Lakh (FY 2025)

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Director10 Jan 20242024₹4.5 Lakh (FY 2025)Active

Board colleagues of Packiri Samy Porselvi

NameDINCompanyDesignation
Krishnan Sankar10459792Grasp Pharamaceuticals Private LimitedDirector

Directorship timeline

Open interactive timeline →
Grasp Pharamaceuticals Private Limited
Premium access

Shareholding and investment profile for Packiri Samy Porselvi

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Packiri Samy Porselvi

Packiri Samy Porselvi currently holds 1 directorship: Grasp Pharamaceuticals Private Limited (Director, since 10 Jan 2024, revenue ₹4.5 Lakh (FY 2025)).

Packiri Samy Porselvi was first appointed on 10 Jan 2024 as Director at Grasp Pharamaceuticals Private Limited.

The current boards of Packiri Samy Porselvi's companies include Krishnan Sankar (Grasp Pharamaceuticals Private Limited).

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available